Here's the Lowdown on Amarin Corporation PLCs 55% Move Higher in March
Small-cap biotech stock Amarin was cleared for takeoff in March on the heels of positive commentary from Wall Street and a better-than-expected earnings report. Find out if shares can rally even higher.
3 Biotech Stocks in Danger of Running Out of Cash
Although running out of money is rare, these three biotech stocks could soon find their bank accounts running dangerously low on cash.